期刊文献+

慢性阻塞性肺疾病急性加重期患者病原学及耐药分析 被引量:5

Etiology and drug resistance analysis of patients with chronic obstructive pulmonary disease of acute exacerbation stage
在线阅读 下载PDF
导出
摘要 目的探讨慢性阻塞性肺疾病(COPD)急性加重期患者病原学及其耐药性特点。方法将我院收治的COPD急性加重期患者128例进行肺功能测定、痰细菌培养、细菌药物敏感试验,根据肺功能将患者分为Ⅰ组(FEV1≥50%预测值)、Ⅱ组(30%预测值<FEV1<50%预测值)、Ⅲ组(FEV1≤30%预测值),分析不同肺功能患者病原学特点和细菌耐药性。结果 128例患者中痰菌定量培养阳性患者96例,阳性率为75.0%,共培养阳性菌105株,其中,革兰阴性菌:铜绿假单胞菌28株(26.7%),大肠埃希菌24株(22.9%),鲍氏不动杆菌15株(14.3%);革兰阳性菌:金黄色葡萄球菌11株(10.5%),表皮葡萄球菌5株(4.8%),肺炎链球菌5株(4.8%);另外白假丝酵母菌7株(6.7%)。部分致病菌呈多重耐药。Ⅰ组患者以痰培养阴性为主,Ⅲ组患者以革兰阳性菌、不动杆菌、大肠埃希菌及铜绿假单胞菌为主,各组患者病原学分布差异有统计学意义(P<0.05)。结论慢性阻塞性肺疾病急性加重期患者细菌感染种类与患者肺功能有一定关系,患者肺功能越差,耐药菌分离率越高,对该类患者应进行细菌培养和药敏试验,应用敏感抗生素治疗。 Objective To explore characteristics of etiology and drug resistance in patients with chronic obstructive pulmonary disease(COPD) of acute exacerbation stage.Methods 128 admitted patients with COPD of acute exacerbation stage,according to their pulmonary function,were divided into three groups: group Ⅰwith forced expiratory volume in the first second(FEV1) no less than 50% of predictive value,group Ⅱ with FEV1 between 30% to 50% of predictive values,and group Ⅲ with FEV1 no more than 30% of predictive value.Characteristics of etiology and drug resistance in varied pulmonary function participants were analyzed.Results There were 96 patients out of 128 cases with positive result of bacterium quantitative culture in sputum,and the positive rate was 75.0%.Among cultured 105 strains of positive bacteria,gram negative bacteria: numbers of pseudomonas aeruginosa,escherichia coli and acinetobacter baumannii were 28 strains(26.7%),24 strains(22.9%) and 15 strains(14.3%) respectively;gram positive bacteria: numbers of staphylococcus aureus,staphylococcus epidermidis and streptococcus pneumonia were in turn 11 strains(10.5%),5 strains(4.8%) and 5 strains(4.8%);candida albicans was 7 strains(6.7%).Part of pathogenic bacteria demonstrated a multi-drug resistance.Outcome of sputum culture in group Ⅰwas mostly negative,while predominant bacteria in group Ⅲ were gram positive bacteria,acinetobacter,escherichia coli and pseudomonadaceae.Etiological distributions in three groups displayed significant differences(P 0.05).Conclusion Bacterial species contracted by COPD patients of acute exacerbation stage have a certain relationship with their pulmonary function.The worse pulmonary function is,the higher possibility drug resistance bacterium is isolated.For such patients,clinical doctors should select sensitive antibiotics to treat after bacterium culture and drug resistance test.
作者 马政权
出处 《中国医药导报》 CAS 2012年第24期99-101,共3页 China Medical Herald
关键词 慢性阻塞性肺疾病 急性加重期 病原学 耐药分析 Chronic obstructive pulmonary disease Acute exacerbation stage Etiology Drug resistance analysis
作者简介 马政权(1976.4-),陕西西安人,学士学位,主治医师;研究方向:呼吸内科。
  • 相关文献

参考文献6

二级参考文献29

共引文献8328

同被引文献50

  • 1蔡柏蔷.慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识(草案)[J].中华哮喘杂志(电子版),2013,7(1):1-13. 被引量:196
  • 2陈新谦,金有豫,汤光.新编药物学[M].17版.北京:人民卫生出版社,2011:37-39.
  • 3Almagro P,Cabrera FJ,Diez J,et al. Comorbidities and short-termprognosis in patients hospitalized for acute exacerbation of COPD:the EPOC en Servicios de medicine interna(ESMI) study[J].Chest,2012,142(5):1126-1133. doi:10.1378/chest.11-2413.
  • 4Magiorakos AP,Srinivasan A,Carey RB,et al. Multidrug-resistamt,extemsively drug- resistant and pandrug- resistant bacteria:aninternational expert proposal for in terim standard definitions foracquired resistance[J].Clin Microbiol Infect,2012,18(3):268-281. doi:10.1111/j.1469-0691.2011.03570.x.
  • 5Domenech A,Puig C,Martí S,et al. Infectious etiology of acuteexacerbations in severe COPD patients[J]. J Infect,2013,67(6):516-523. doi:10.1016/j.jinf.2013.09.003.
  • 6Lee SJ,Lee SH,Kim YE,et al. Clinical features according to thefrequency of acute exacerbation in COPD[J]. Tuberc Respir Dis(Seoul),2012,72(4):367-373. doi:10.4046/trd.2012.72.4.367.
  • 7Eisner MD,Anthonisen N,Coultas D,et al. An official AmericanThoracic Society public policy statement:Novel risk factors and theglobal burden of chronic obstructive pulmonary disease[J]. Am JRespir Crit Care Med,2010,182(5):693- 718. doi:10.1164/rccm.200811-1757ST.
  • 8Leuppi JD,Schuetz P,Bingisser R,et al. Short-term vs conventionalglucocorticoid therapy in acute exacerbations of chronic obstructivepulmonary disease:the REDUCE randomized clinical trial[J]. JAMA,2013,309(21):2223-2231. doi:10.1001/jama.2013.5023.
  • 9Klapdor B,Ewig S. Antimicrobial treatment of patients with severeacute exacerbation of COPD[J]. Med Klin Intensivmed Notfmed,2012,107(3):179-184. doi:10.1007/s00063-011-0066-x.
  • 10王以炳,杨玉梅,谢艳丽,刘莉敏,夏蕾,李玉磊,张天民.左氧氟沙星治疗AECOPD下呼吸道细菌感染安全性与有效性的对比分析[J].临床肺科杂志,2008,13(11):1406-1407. 被引量:5

引证文献5

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部